Company intelligence / Profile preview

Explicyte Immuno-Oncology

Bordeaux, Nouvelle-Aquitaine, France

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Explicyte is a French biotechnology company and contract research organization (CRO) specializing in immuno-oncology. The company provides a comprehensive suite of preclinical services, including in vitro and in vivo modeling, biomarker discovery, and advanced spatial biology. Beyond its service offerings, Explicyte maintains an internal R&D pipeline focused on the kynurenine pathway and other metabolic checkpoints to identify novel therapeutic targets. The company leverages digital pathology and bioinformatics to accelerate the development of next-generation cancer immunotherapies for its global partners.

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibodyBiologic
Industry: Biotech

Beyond the preview

Go deeper on Explicyte Immuno-Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Explicyte Immuno-Oncology.

Explore the full profile